GLP-1s, taste and what’s happening to our diets
Trump announces lower prices coming for GLP-1 drugs Zepbound, Wegovy President Donald Trump announces discounted pricing for Zepbound…
Medical Product Alert N°7/2025: Falsified IBRANCE (palbociclib)
Alert Summary This WHO Medical Product Alert refers to nine lots of falsified IBRANCE (palbociclib). These falsified products…
Etripamil Nasal Spray Gains FDA Approval for Acute Paroxysmal SVT
The self-administered treatment rapidly converts patients into sinus rhythm and may reduce trips to the hospital. The US…
$21,500 in illegally made cough syrup and prescription medicine seized in Joo Chiat raid
SINGAPORE – More than 31 litres of illegal cough syrup and over 5,200 units of addictive prescription medicine…
Govt Medicines Meant For Patients Found Dumped On Roadside In Balasore
Balasore: A bizarre incident has come to light in Balasore district, where a huge quantity of government medicines…
Belfast man warns of danger of ‘hidden addiction’ to over-the-counter medication
A recovering Belfast man has warned of the dangers of the often hidden addiction to over-the-counter medication. Michael…
Iran drug stocks under two months, 800 medicines at risk as FX delays bite
“The Islamic Republic has invaded Venezuela alongside its allies Russia and its proxy Hezbollah. To those who claim…
Festive foods and your medicines: MHRA shares advice to help you stay safe this winter
As the festive season approaches, many of us enjoy foods and drinks that aren’t part of our usual…
FDA OKs libido-boosting pill for older women who have gone through menopause
WASHINGTON (AP) — U.S. health officials have expanded approval of a much-debated drug aimed at boosting female libido,…
Nasal Spray Sold Nationwide Recalled Due to Yeast, Mold, Microbial Contamination
A nasal spray that was distributed nationwide has been recalled due to potential contamination, the Food and Drug Administration and…
The herb linked to better memory, lower anxiety and Alzheimer’s protection
Your support helps us to tell the story From reproductive rights to climate change to Big Tech, The…
UK approves the first twice yearly biological medicine for asthma and severe chronic rhinosinusitis with nasal polyps
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (15 December 2025) approved depemokimab (Exdensur), the first…